{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:39:50Z","timestamp":1788716390103,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0410001"],"award-info":[{"award-number":["JP18fk0410001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16fk0310501"],"award-info":[{"award-number":["JP16fk0310501"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310101"],"award-info":[{"award-number":["JP20fk0310101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk031011 3"],"award-info":[{"award-number":["JP20fk031011 3"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K19577"],"award-info":[{"award-number":["17K19577"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["H04222"],"award-info":[{"award-number":["H04222"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04222"],"award-info":[{"award-number":["17H04222"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jhep.2020.12.006","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T03:27:55Z","timestamp":1608089275000},"page":"1075-1086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of a novel long-acting 4\u2019-modified nucleoside reverse transcriptase inhibitor against HBV"],"prefix":"10.1016","volume":"74","author":[{"given":"Nobuyo","family":"Higashi-Kuwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9164-9152","authenticated-orcid":false,"given":"Sanae","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Ogata-Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-5888","authenticated-orcid":false,"given":"Debananda","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Venzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haydar","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Otagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutoki","family":"Takamune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9401-8118","authenticated-orcid":false,"given":"Naoki","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Misumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Kakuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2473-6966","authenticated-orcid":false,"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mitsuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.12.006_bib1","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2020.12.006_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cld.782","article-title":"Treatment for advanced hepatocellular carcinoma: current standard and the future","volume":"13","author":"Likhitsup","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jhep.2020.12.006_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cld.2019.04.008","article-title":"WHO guidelines for prevention, Care and treatment of individuals infected with HBV: a US perspective","volume":"23","author":"Vittal","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2020.12.006_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cld.2019.04.006","article-title":"Drugs in the pipeline for HBV","volume":"23","author":"Lopatin","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"8","key":"10.1016\/j.jhep.2020.12.006_bib5","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/AAC.00277-07","article-title":"Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine","volume":"51","author":"Nakata","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2020.12.006_bib6","article-title":"MK-8591 at doses of 0.25 to 2.25 mg QD, in combination with doravirine establishes and maintains viral suppression through 48 weeks in treatment-na\u00efve adults with HIV-1 infection","author":"Molina","year":"2019","journal-title":"IAS"},{"key":"10.1016\/j.jhep.2020.12.006_bib7","unstructured":"Game-changer for treatment and prophylaxis of HIV infection: https:\/\/www.independent.co.uk\/news\/health\/hiv-cure-implant-prevent-aids-drugs-pills-lgbt-safe-sex-a9020551.html."},{"key":"10.1016\/j.jhep.2020.12.006_bib8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep.27962","article-title":"4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus","volume":"62","author":"Takamatsu","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.12.006_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02143-18","article-title":"CMCdG, a novel nucleoside analog with favorable safety features, exerts potent activity against wild-type and entecavir-resistant hepatitis B virus","volume":"63","author":"Higashi-Kuwata","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jhep.2020.12.006_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jhep.2020.12.006_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.01122-07","article-title":"Entecavir for treatment of hepatitis B virus displays no in\u00a0vitro mitochondrial toxicity or DNA polymerase gamma inhibition","volume":"52","author":"Mazzucco","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2020.12.006_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.dmpk.2016.09.004","article-title":"Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter","volume":"32","author":"Furihata","year":"2017","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jhep.2020.12.006_bib13","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1073\/pnas.84.7.2033","article-title":"Long-term inhibition of human T-lymphotropic virus type III\/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in\u00a0vitro","volume":"84","author":"Mitsuya","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2020.12.006_bib14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0016-5085(89)91699-5","article-title":"Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase","volume":"97","author":"Kassianides","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.12.006_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1021\/jm00165a015","article-title":"Acid-stable\u00a02'-fluoro purine dideoxynucleosides as active agents against HIV","volume":"33","author":"Marquez","year":"1990","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jhep.2020.12.006_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0731-7085(99)00276-9","article-title":"Stability study of selected adenosine nucleosides using LC and LC\/MS analyses","volume":"22","author":"Abdel-Hamid","year":"2000","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.jhep.2020.12.006_bib17","first-page":"91","article-title":"Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones","volume":"72","author":"Murakami","year":"2016","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jhep.2020.12.006_bib18","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/0091270006293304","article-title":"Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects","volume":"46","author":"Yan","year":"2006","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jhep.2020.12.006_bib19","doi-asserted-by":"crossref","first-page":"9274","DOI":"10.1073\/pnas.1605223113","article-title":"Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)","volume":"113","author":"Salie","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jhep.2020.12.006_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/COH.0000000000000599","article-title":"Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1","volume":"15","author":"Markowitz","year":"2020","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:10:24Z","timestamp":1778674224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820338435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0168827820338435"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.12.006","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel long-acting 4\u2019-modified nucleoside reverse transcriptase inhibitor against HBV","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}